CE Activities

The Sickle Cell Disease (SCD) Continuing Education section will contain a multimedia collection of continuing education activities focusing on ongoing evidence-based scientific data and resources for treating SCD in your clinical practice.

Therapies for Adult Patients with Sickle Cell Disease
Therapies for Adult Patients with Sickle Cell Disease
CME, CNE
Lanetta Bronté-Hall, MD, MPH, MSPH
Release Date: October 27, 2021
Expiration Date: October 27, 2022

In this activity, Dr. Bronté-Hall discusses the care and management of adult patients with sickle cell disease. This activity will conclude with a review of the Florida-based quality improvement study, designed to improve quality of care for patients, and how to implement and monitor the standard of care. Don't miss the opportunity to participate in this QI program led by Dr. Bronté-Hall. Information on how you can participate will be provided at the end of the program.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Novartis Pharmaceuticals.
Begin, Earn CreditView Only, No Credit
 
Therapies for Pediatric Patients with Sickle Cell Disease
Therapies for Pediatric Patients with Sickle Cell Disease
CME, CNE
Lanetta Bronté-Hall, MD, MPH, MSPH, and Andrew Campbell, MD
Release Date: October 25, 2021
Expiration Date: October 25, 2022

In this activity, two experts discuss the care of pediatric patients with sickle cell disease, including updated information on therapies. This activity will conclude with a review of the Florida-based quality improvement study, designed to improve quality of care for patients, and how to implement and monitor the standard of care. Don't miss the opportunity to participate in this QI program led by Dr. Bronté-Hall. Information on how you can participate will be provided at the end of the program. ​

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Novartis Pharmaceuticals.
Begin, Earn CreditView Only, No Credit
 
African Americans, Sickle Cell Disease, and  COVID-19: Dispelling Myths and Addressing Facts
African Americans, Sickle Cell Disease, and COVID-19: Dispelling Myths and Addressing Facts
CME, CPE
Lanetta Bronté-Hall, MD, MPH, MSPH
Release Date: December 21, 2020
Expiration Date: December 21, 2021

The impact of COVID-19 on the routine management of patients with sickle cell disease (SCD) has been substantial and complex, as clinicians now need to ensure that patients receive appropriate care for SCD in balance with the challenges posed by the pandemic. In this article, Lanetta Bronté-Hall, MD, MPH, MSPH discusses the current data regarding the prevalence of COVID-19 among patients with SCD and provides guidance on best practice on the treatment and monitoring of SCD during the COVID-19 pandemic.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Global Blood Therapeutics.
Begin, Earn CreditView Only, No Credit